Health Care [ 12/12 ] | Life Sciences Tools & Services [ 71/74 ]
NASDAQ | Common Stock
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome.
It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.
The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes.
It operates in China, Australia, Eastern Europe, Israel, and Japan.
The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018.
Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 8, 24 | -0.35 Increased by +5.41% | -0.36 Increased by +2.78% |
| May 8, 24 | -0.32 Increased by +15.79% | -0.30 Decreased by -6.67% |
| Feb 29, 24 | -0.28 Increased by +22.22% | -0.37 Increased by +24.32% |
| Nov 7, 23 | -0.33 Increased by +13.16% | -0.40 Increased by +17.50% |
| Aug 8, 23 | -0.37 Increased by 0.00% | -0.39 Increased by +5.13% |
| May 9, 23 | -0.38 Increased by 0.00% | -0.38 |
| Mar 2, 23 | -0.36 Decreased by -12.50% | -0.43 Increased by +16.28% |
| Nov 8, 22 | -0.38 Decreased by -26.67% | -0.39 Increased by +2.56% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 4.03 M Increased by +5.72% | -21.33 M Decreased by -1.14% | Decreased by -528.97% Increased by +4.33% |
| Jun 30, 24 | 3.07 M Decreased by -11.47% | -22.85 M Increased by +2.48% | Decreased by -743.82% Decreased by -10.15% |
| Mar 31, 24 | 3.07 M Decreased by -17.54% | -20.68 M Decreased by -1.01% | Decreased by -674.46% Decreased by -22.49% |
| Dec 31, 23 | 4.18 M Increased by +8.32% | -17.80 M Increased by +9.86% | Decreased by -425.81% Increased by +16.79% |
| Sep 30, 23 | 3.81 M Decreased by -3.57% | -21.09 M Increased by +7.89% | Decreased by -552.91% Increased by +4.48% |
| Jun 30, 23 | 3.47 M Decreased by -2.83% | -23.43 M Decreased by -5.56% | Decreased by -675.24% Decreased by -8.64% |
| Mar 31, 23 | 3.72 M Increased by +12.73% | -20.47 M Increased by +12.90% | Decreased by -550.65% Increased by +22.74% |
| Dec 31, 22 | 3.86 M Increased by +27.28% | -19.75 M Decreased by -0.04% | Decreased by -511.71% Increased by +21.40% |